# A Study in Participants With Type 1 Diabetes Mellitus

> **NCT01481779** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 455 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Glargine
- **DRUG:** LY2605541
- **DRUG:** Insulin Lispro

## Key facts

- **NCT ID:** NCT01481779
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-05
- **Final completion:** 2014-06
- **Target enrollment:** 455 (ACTUAL)
- **Last updated:** 2018-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01481779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01481779, "A Study in Participants With Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01481779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*